These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 10215749)

  • 1. Pharmacokinetics of intravenous and oral L-arginine in normal volunteers.
    Tangphao O; Grossmann M; Chalon S; Hoffman BB; Blaschke TF
    Br J Clin Pharmacol; 1999 Mar; 47(3):261-6. PubMed ID: 10215749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of L-arginine during chronic administration to patients with hypercholesterolaemia.
    Tangphao O; Chalon S; Moreno H; Hoffman BB; Blaschke TF
    Clin Sci (Lond); 1999 Feb; 96(2):199-207. PubMed ID: 9918901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An oral yohimbine/L-arginine combination (NMI 861) for the treatment of male erectile dysfunction: a pharmacokinetic, pharmacodynamic and interaction study with intravenous nitroglycerine in healthy male subjects.
    Kernohan AF; McIntyre M; Hughes DM; Tam SW; Worcel M; Reid JL
    Br J Clin Pharmacol; 2005 Jan; 59(1):85-93. PubMed ID: 15606445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absolute oral bioavailability of traxoprodil in cytochrome P450 2D6 extensive and poor metabolisers.
    Taylor TJ; Diringer K; Russell T; Venkatakrishnan K; Wilner K; Crownover PH; Benincosa LJ; Gibbs MA
    Clin Pharmacokinet; 2006; 45(10):989-1001. PubMed ID: 16984212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The absolute oral bioavailability and population-based pharmacokinetic modelling of a novel dipeptidylpeptidase-IV inhibitor, vildagliptin, in healthy volunteers.
    He YL; Sadler BM; Sabo R; Balez S; Wang Y; Campestrini J; Laurent A; Ligueros-Saylan M; Howard D
    Clin Pharmacokinet; 2007; 46(9):787-802. PubMed ID: 17713976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. L-arginine-induced vasodilation in healthy humans: pharmacokinetic-pharmacodynamic relationship.
    Bode-Böger SM; Böger RH; Galland A; Tsikas D; Frölich JC
    Br J Clin Pharmacol; 1998 Nov; 46(5):489-97. PubMed ID: 9833603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of 1,25(OH)(2)D(3) and 1alpha(OH)D(3) in normal and uraemic men.
    Brandi L; Egfjord M; Olgaard K
    Nephrol Dial Transplant; 2002 May; 17(5):829-42. PubMed ID: 11981071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cilostazol pharmacokinetics after single and multiple oral doses in healthy males and patients with intermittent claudication resulting from peripheral arterial disease.
    Bramer SL; Forbes WP; Mallikaarjun S
    Clin Pharmacokinet; 1999; 37 Suppl 2():1-11. PubMed ID: 10702882
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary pharmacokinetic study of ibuprofen enantiomers after administration of a new oral formulation (ibuprofen arginine) to healthy male volunteers.
    Fornasini G; Monti N; Brogin G; Gallina M; Eandi M; Persiani S; Bani M; Della Pepa C; Zara G; Strolin Benedetti M
    Chirality; 1997; 9(3):297-302. PubMed ID: 9176996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of food on the absorption and pharmacokinetics of rivaroxaban.
    Stampfuss J; Kubitza D; Becka M; Mueck W
    Int J Clin Pharmacol Ther; 2013 Jul; 51(7):549-61. PubMed ID: 23458226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the safety and pharmacokinetics of ST-246® after i.v. infusion or oral administration in mice, rabbits and monkeys.
    Chen Y; Amantana A; Tyavanagimatt SR; Zima D; Yan XS; Kasi G; Weeks M; Stone MA; Weimers WC; Samuel P; Tan Y; Jones KF; Lee DR; Kickner SS; Saville BM; Lauzon M; McIntyre A; Honeychurch KM; Jordan R; Hruby DE; Leeds JM
    PLoS One; 2011; 6(8):e23237. PubMed ID: 21858040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic-pharmacodynamic profile of systemic nitric oxide-synthase inhibition with L-NMMA in humans.
    Mayer BX; Mensik C; Krishnaswami S; Derendorf H; Eichler HG; Schmetterer L; Wolzt M
    Br J Clin Pharmacol; 1999 May; 47(5):539-44. PubMed ID: 10336578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of age on the pharmacokinetics and pharmacodynamics of ximelagatran, an oral direct thrombin inhibitor.
    Johansson LC; Frison L; Logren U; Fager G; Gustafsson D; Eriksson UG
    Clin Pharmacokinet; 2003; 42(4):381-92. PubMed ID: 12648028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of intravenous and oral enoxacin in healthy volunteers.
    Chang T; Black A; Dunky A; Wolf R; Sedman A; Latts J; Welling PG
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():49-56. PubMed ID: 3162901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of therapeutic doses of tropisetron in healthy volunteers.
    Kees F; Färber L; Bucher M; Mair G; Mörike K; Grobecker H
    Br J Clin Pharmacol; 2001 Dec; 52(6):705-7. PubMed ID: 11736884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of epoetin delta in two studies in healthy volunteers and two studies in patients with chronic kidney disease.
    Smith WB; Dowell JA; Pratt RD
    Clin Ther; 2007 Jul; 29(7):1368-80. PubMed ID: 17825688
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic properties of oral L-citrulline and L-arginine: impact on nitric oxide metabolism.
    Schwedhelm E; Maas R; Freese R; Jung D; Lukacs Z; Jambrecina A; Spickler W; Schulze F; Böger RH
    Br J Clin Pharmacol; 2008 Jan; 65(1):51-9. PubMed ID: 17662090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and pharmacodynamic modeling of the effects of oral and intravenous administrations of dofetilide on ventricular repolarization.
    Le Coz F; Funck-Brentano C; Morell T; Ghadanfar MM; Jaillon P
    Clin Pharmacol Ther; 1995 May; 57(5):533-42. PubMed ID: 7768076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma profiles of lycopene after single oral and intravenous administrations in dogs.
    Vertzoni M; Valsami G; Reppas C
    J Pharm Pharmacol; 2006 Sep; 58(9):1211-7. PubMed ID: 16945179
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.